1. Home
  2. RAPT vs UMAC Comparison

RAPT vs UMAC Comparison

Compare RAPT & UMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • UMAC
  • Stock Information
  • Founded
  • RAPT 2015
  • UMAC 2019
  • Country
  • RAPT United States
  • UMAC United States
  • Employees
  • RAPT N/A
  • UMAC N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • UMAC
  • Sector
  • RAPT Health Care
  • UMAC
  • Exchange
  • RAPT Nasdaq
  • UMAC Nasdaq
  • Market Cap
  • RAPT 117.5M
  • UMAC 134.1M
  • IPO Year
  • RAPT 2019
  • UMAC 2024
  • Fundamental
  • Price
  • RAPT $7.35
  • UMAC $8.18
  • Analyst Decision
  • RAPT Buy
  • UMAC Strong Buy
  • Analyst Count
  • RAPT 5
  • UMAC 2
  • Target Price
  • RAPT $42.00
  • UMAC $19.00
  • AVG Volume (30 Days)
  • RAPT 120.8K
  • UMAC 6.0M
  • Earning Date
  • RAPT 08-07-2025
  • UMAC 08-13-2025
  • Dividend Yield
  • RAPT N/A
  • UMAC N/A
  • EPS Growth
  • RAPT N/A
  • UMAC N/A
  • EPS
  • RAPT N/A
  • UMAC N/A
  • Revenue
  • RAPT N/A
  • UMAC $6,988,704.00
  • Revenue This Year
  • RAPT N/A
  • UMAC $160.90
  • Revenue Next Year
  • RAPT N/A
  • UMAC $135.75
  • P/E Ratio
  • RAPT N/A
  • UMAC N/A
  • Revenue Growth
  • RAPT N/A
  • UMAC 1029.19
  • 52 Week Low
  • RAPT $5.67
  • UMAC $1.13
  • 52 Week High
  • RAPT $30.60
  • UMAC $23.62
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 43.57
  • UMAC 55.78
  • Support Level
  • RAPT $6.88
  • UMAC $7.70
  • Resistance Level
  • RAPT $8.91
  • UMAC $10.78
  • Average True Range (ATR)
  • RAPT 0.70
  • UMAC 1.49
  • MACD
  • RAPT -0.16
  • UMAC 0.16
  • Stochastic Oscillator
  • RAPT 11.36
  • UMAC 54.23

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About UMAC Unusual Machines Inc. Common Stock

Unusual Machines Inc is engaged in serving the American drone industry by building and selling drone components.

Share on Social Networks: